Audit on Anemia Variation After Major Gynacological Surgery
an Audit on Postoperative Variations in Anemia Treatment After Major Gynecological Surgery
1 other identifier
observational
70
1 country
1
Brief Summary
The study aims to increase our understanding of variability in adherence to anaemia management guidelines and to assess the impact of anaemia management in clinical care following major gynaecological surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedMarch 15, 2022
March 1, 2022
7 months
November 20, 2021
March 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the rate of anemia after major gynecological surgery
percentage of patients with anemia after surgery
one month
Eligibility Criteria
any female 18 to 60 years undegoing major gynecological surgery
You may qualify if:
- Age: Adult, 18\_60 years
- Procedure: A major gynecological surgery is defined as an operation with an incision into the abdominal cavity and anticipated duration of more than one hour. Procedures performed using any surgical approach, including open and laparoscopic surgery are included.
- Urgency: Patients undergoing planned (elective or expedited) or unplanned (emergency) surgery
You may not qualify if:
- Procedures: surgery classified as minor operations such as; diagnostic laparoscopy (emergency or elective), D\&C.
- Indication: Palliative procedures as determined pre-operatively and explicitly stated in the medical record or consent form.
- Return to theatre: Each patient should only be included in the study once. Patients returning to theatre due to complications following earlier surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assuit university
Multiple Locations, Egypt
Related Publications (2)
Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996 Oct 19;348(9034):1055-60. doi: 10.1016/S0140-6736(96)04330-9.
PMID: 8874456BACKGROUNDMcLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009 Apr;12(4):444-54. doi: 10.1017/S1368980008002401. Epub 2008 May 23.
PMID: 18498676BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
sayed mostafa
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 20, 2021
First Posted
March 15, 2022
Study Start
December 1, 2021
Primary Completion
June 30, 2022
Study Completion
July 1, 2023
Last Updated
March 15, 2022
Record last verified: 2022-03